Brought to you by 
Active Pass brings in $3.4mm
10 Aug 2000
Executive Summary
Canadian genomics start-up Active Pass Pharmaceuticals completed a $3.4mm ($Cdn5mm) private placement to return investors Working Opportunity Fund (managed by GrowthWorks Capital Ltd.) and Navigator Canadian Technology Fund (managed by Nova Bancorp Investment Management), and new investors Future Fund Capital, BioFuture Fund Capital, and several individual investors.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Active Pass brings in $3.4mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice